$3.83
+0.08 (+2.13%)
Open$3.76
Previous Close$3.75
Day High$3.84
Day Low$3.70
52W High$11.68
52W Low$3.64
Volume—
Avg Volume14.8K
Market Cap48.09M
P/E Ratio—
EPS$-1.12
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+801.0% upside
Current
$3.83
$3.83
Target
$34.51
$34.51
$26.32
$34.51 avg
$56.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.75M | 2.40M | 21.69M |
| Net Income | -13,462,696 | -10,574,643 | 2.61M |
| Profit Margin | -490.0% | -465.5% | 12.0% |
| EBITDA | -13,315,563 | -11,040,133 | 4.63M |
| Free Cash Flow | — | — | 2.95M |
| Rev Growth | +14.6% | +14.6% | +19.5% |
| Debt/Equity | 0.03 | 0.03 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |